Literature DB >> 25245247

Prostate cancer: targeting the FGFR curbs bone metastasis.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25245247     DOI： 10.1038/nrurol.2014.270

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases.

Authors:  Xinhai Wan; Paul G Corn; Jun Yang; Nallasivam Palanisamy; Michael W Starbuck; Eleni Efstathiou; Elsa M Li Ning Tapia; Elsa M Li-Ning Tapia; Amado J Zurita; Ana Aparicio; Murali K Ravoori; Elba S Vazquez; Dan R Robinson; Yi-Mi Wu; Xuhong Cao; Matthew K Iyer; Wallace McKeehan; Vikas Kundra; Fen Wang; Patricia Troncoso; Arul M Chinnaiyan; Christopher J Logothetis; Nora M Navone
Journal:  Sci Transl Med       Date:  2014-09-03       Impact factor: 17.956
  1 in total
  2 in total

Review 1.  Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase.

Authors:  Mariana Quiroz-Munoz; Sudeh Izadmehr; Dushyanthy Arumugam; Beatrice Wong; Alexander Kirschenbaum; Alice C Levine
Journal:  J Endocr Soc       Date:  2019-02-01

2.  FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma.

Authors:  Tao Chen; Fei Wang; Shupei Wei; Yingjie Nie; Xiaotao Zheng; Yu Deng; Xubin Zhu; Yuezhen Deng; Nanshan Zhong; Chengzhi Zhou
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.